SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-25-030653 from Aquaron Acquisition Corp. (AQUNR)

Aquaron Acquisition Corp.
Date: April 10, 2025 · CIK: 0001861063 · Accession: 0001213900-25-030653

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-41470

Referenced dates: April 9, 2025

Date
April 10, 2025
Author
/s/ Yi Zhou
Form
CORRESP
Company
Aquaron Acquisition Corp.

Letter

Aquaron Acquisition Corp.

April 10, 2025

Via Edgar

Division of Corporation Finance

Office of Real Estate & Construction

U.S. Securities and Exchange Commission

Attention: Isabel Rivera

Benjamin Holt

Re: Aquaron Acquisition Corp.

Preliminary Proxy Statement on Schedule 14A

Filed April 4, 2025

File No. 001-41470

Ladies and Gentlemen:

This letter is in response to the letter dated April 9, 2025, from the staff (the "Staff") of the U.S. Securities and Exchange Commission (the "Commission") addressed to Aquaron Acquisition Corp. (the "Company," "we," or "our"). For ease of reference, we have recited the Commission's comments in this response and numbered them accordingly.

Preliminary Proxy Statement on Schedule 14A filed April 4, 2025

General

1.

We note your disclosure that your common stock is quoted on the over-the-counter trading market. We also note your Form 8-K filed March 10, 2025, in which you disclosed the determination letter received from Nasdaq on March 6, 2025 stating that Nasdaq will suspend trading in the company's common stock effective at the opening of trading on March 7, 2025. Please update your disclosure throughout the proxy statement to clearly disclose, if true, that your securities were delisted on March 7, 2025 and are now quoted on the over-the-counter trading market. Also revise to address the consequences arising from the delisting to you and your shareholders, including the impacts on your liquidity and the market for your securities, your attractiveness as a merger partner, your ability to complete your business combination, and your securities no longer being "covered securities." In this regard, we note, for example, that your merger agreement dated July 12, 2024 with HUTURE Ltd. and other parties contains a representation and a closing condition regarding your listing on Nasdaq.

Response : In response to the Staff's comment, the Company has included a new risk factor on page 2 of the Amended Preliminary Proxy Statement.

We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Sally Yin, Esq., of Hunter Taubman Fischer & Li LLC, at 929-226-4130.

Very truly yours,
/s/ Yi Zhou

Show Raw Text
CORRESP
 1
 filename1.htm

 Aquaron Acquisition Corp.

 April 10, 2025

 Via Edgar

 Division of Corporation Finance

 Office of Real Estate & Construction

 U.S. Securities and Exchange Commission

 Attention:
 Isabel Rivera

 Benjamin Holt

 Re:
 Aquaron Acquisition Corp.

 Preliminary Proxy Statement on Schedule 14A

 Filed April 4, 2025

 File No. 001-41470

 Ladies and Gentlemen:

 This letter is in response to the letter dated
April 9, 2025, from the staff (the "Staff") of the U.S. Securities and Exchange Commission (the "Commission")
addressed to Aquaron Acquisition Corp. (the "Company," "we," or "our"). For ease of reference, we
have recited the Commission's comments in this response and numbered them accordingly.

 Preliminary Proxy Statement on Schedule 14A filed April 4, 2025

 General

 1.

 We
 note your disclosure that your common stock is quoted on the over-the-counter trading market. We also note your Form 8-K filed March 10,
 2025, in which you disclosed the determination letter received from Nasdaq on March 6, 2025 stating that Nasdaq will suspend trading in
 the company's common stock effective at the opening of trading on March 7, 2025. Please update your disclosure throughout the proxy
 statement to clearly disclose, if true, that your securities were delisted on March 7, 2025 and are now quoted on the over-the-counter
 trading market. Also revise to address the consequences arising from the delisting to you and your shareholders, including the impacts
 on your liquidity and the market for your securities, your attractiveness as a merger partner, your ability to complete your business
 combination, and your securities no longer being "covered securities." In this regard, we note, for example, that your merger
 agreement dated July 12, 2024 with HUTURE Ltd. and other parties contains a representation and a closing condition regarding your
 listing on Nasdaq.

 Response :
 In response to the Staff's comment, the Company has included a new risk factor on page 2 of the Amended Preliminary Proxy Statement.

 We appreciate the assistance the Staff has provided
with its comments. If you have any questions, please do not hesitate to call our counsel, Sally Yin, Esq., of Hunter Taubman Fischer &
Li LLC, at 929-226-4130.

 Very truly yours,

 /s/ Yi Zhou

 Name:
 Yi Zhou

 Title:
 Chief Executive Officer

 Cc: Sally Yin, Esq.

 Hunter Taubman Fischer & Li LLC